Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Ovarian Cancer Genome Mapped, Opens Door to Personalized Medicine

June 29, 2011 9:36 am | by Lawrence Berkeley National Laboratory | News | Comments

Scientists have developed the first comprehensive catalog of the genetic aberrations responsible for an aggressive type of ovarian cancer that accounts for 70 percent of all ovarian cancer deaths. Hundreds of researchers from more than 80 institutions, including scientists from Berkeley...

Ascension Orthopedics Implants PyroTITANâ„¢ in Geelong, Australia

June 29, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, June 29, 2011 /- Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard S. Page, MB.BS.FRACS(ORTH) at St. John of God Hospital. "The...

Scientists Identify Order of Mutations that Lead to Cancer

June 29, 2011 9:33 am | by AACR | News | Comments

Tweet   • Findings represent a critical step in personalizing cancer treatments. • Some early aberrations are required for development of later abnormalities. PHILADELPHIA - Scientists have begun to reveal the order of the genetic aberrations in individual cancers in a finding they...


UBM Canon's Virtual Event Dedicated to Developments in Materials for Medical Applications

June 29, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

CHICAGO, June 29, 2011 /- UBM Canon's publishing group's leading brands European Medical Device Technology ( EMDT ), Medical Device and Diagnostic Industry ( MD+DI ) and Qmed® presented " Developments in Materials for Medical Applications " on May 24, 2011.  Devoted to...

Care for a Massage with Your Free Mammogram?

June 29, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

FLINT, Mich., June 29, 2011 /- During National Women's Health Week, RMI (Regional Medical Imaging), a leading women's imaging provider based in Flint, announced that they would offer free screening mammograms to up to 50 area women who had been impacted by unemployment or were otherwise...

ECRI Institute and Health Care Improvement Foundation Launch CT Radiation Safety Collaborative

June 29, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., June 29, 2011 /PRNewswire-USNewswire/ -- ECRI Institute , an independent nonprofit that researches the best approaches to improving patient care, and the Health Care Improvement Foundation , an independent nonprofit corporation with a multi-dimensional focus on...

Video Features World's First Essential Tremor Patient Treated With Noninvasive MR-Guided Focused Ultrasound

June 29, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CHARLOTTESVILLE, Va., June 29, 2011 /PRNewswire-USNewswire/ -- The last ten years have been challenging for Billy R. Williams of Fort Valley, Virginia. The former Pentagon employee, who survived the 9/11 terrorist attack, has suffered from essential tremor, a progressive and debilitating...

USPTO Issues Patent for CardioGenics' Signal Amplification Technology

June 29, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, June 29, 2011 /- CardioGenics Holdings Inc. (CGNH.OB) announced today that the United States Patent & Trademark Office (USPTO) has notified the company that its patent application has been granted (issued patent # 7,964,415). This patent covers CardioGenics...


Tris Pharma Appoints Vice President of Human Resources

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

MONMOUTH JUNCTION, N.J., June 29, 2011 /- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, has appointed Ms. Cheryl Patnick to the position of Vice President of Human Resources. Ms. Patnick had been working with Tris as a consultant for...

Suneva Medical Announces Canadian Approval of Bellafillâ„¢

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 29, 2011 /- Suneva Medical, a privately-held aesthetic medical device company, today announced the expansion of its core aesthetics injectable business with approval from Health Canada to market Bellafill ™ , its long lasting dermal filler for nasolabial folds or...

Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., June 29, 2011 /- Micell Technologies, Inc. today announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent Drug-Eluting Coronary Stent System ("MiStent DES"), an...

Cayenne Medical, Inc. Launches CrossFix® II Meniscal Repair System

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SCOTTSDALE, Ariz., June 29, 2011 /- Cayenne Medical, Inc., a private sports medicine device company, announces the launch of CrossFix® II Meniscal Repair System, its second generation device for treatment of traumatic meniscal tears. CrossFix® II will be on display at the 2011...

ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., June 29, 2011 /- ZONARE Medical Systems, a global developer of high-end ultrasound systems, today announced it ranked highest in performance across a number of clinical applications and ranked first or second in several customer support and service categories in the...


UBM Canon Announces New Japanese-Language Website for Japan Medical Design & Manufacturing Technology:

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, June 29, 2011 /- UBM Canon's leading brand, Japan Medical Design & Manufacturing Technology ( JMD&MT ) today announced the launch of its new Japanese-language website with enhanced content and functionality at . "This new website allows users to find the...

Unilife Successfully Completes Industrialization of Unifill Syringe

June 29, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

YORK, Pa., June 29, 2011 /- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS ; ASX: UNS) today announced that it has successfully completed the validation phase of the Unifill® ready-to-fill (prefilled) syringe. This key industrial milestone represents the final step in...

United Lincolnshire Hospitals NHS Trust Selects Jayex QI Interactive Patient Survey and Information Management Kiosk

June 29, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

LONDON, June 29, 2011 /-   - Jayex ' s QI Touch Screen Solution Enables the Trust to Instantly Review Patient Feedback to Assist in the Delivery of High-Quality Patient Centred Care - Jayex, the healthcare display technology specialist, today announces that...

Perrigo Provides Update on Acquisition of Paddock Labs

June 29, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

ALLEGAN, Mich., June 29, 2011 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it continues to work to finalize  the regulatory approvals necessary to complete the acquisition of Paddock Laboratories, Inc. ("Paddock"), a privately-held, Minneapolis-based pharmaceutical...

Bioengineers expanding work to solve cardiovascular health challenges

June 29, 2011 3:33 am | by Arizona State University | News | Comments

Three ASU bioengineers will expand their research into treatment of brain aneurysms and cardiovascular ailments with support from the American Heart Associationread more

CardioFocus HeartLightâ„¢ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

MARLBOROUGH, Mass., June 29, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today  that its technology was featured in a live case and scientific abstract presented at the...

Concord Medical Services Files 2010 Annual Report on Form 20-F

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

BEIJING, June 29, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that on June 28, 2011, it filed...

DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., June 29, 2011 /- In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program.  NASA recently followed that...

Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstageâ„¢ GCC Colorectal Cancer Staging Test

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK and QUEBEC CITY, June 29, 2011 /- Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc. (TSX: CUR), a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a...

Amsterdam Molecular Therapeutics' Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients

June 28, 2011 11:31 pm | by Bio-Medicine.Org | News | Comments

AMSTERDAM, June 29, 2011 /- Data Presented at the 79 th European Atherosclerosis Society Meeting Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today released data showing that its gene therapy Glybera® (alipogene tiparvovec)...

Burlington Medical Supplies Introduces Single Swing-Arm Drape

June 28, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

NEWPORT NEWS, Va., June 28, 2011 /-  Burlington Medical Supplies, headquartered in Newport News, Virginia, has introduced a new product into its inventory. The Single Swing-Arm Drape attaches to a medical procedure table's arm extension and protects the worker from any scattered...

The Lancet Publishes Data from Protege, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients

June 28, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., June 28, 2011 /- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of results from Protege, a Phase 3 clinical study of...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.